Brief: Elaris Advances C. Difficile Vaccine Beyond Toxin-Only Approaches With Matrivax Asset Acquisition

Elaris AG

05/05/2026 13:33

May 5 (Reuters) - Elaris AG ELSn.MU:

ELARIS ADVANCES C. DIFFICILE VACCINE BEYOND TOXIN-ONLY APPROACHES WITH MATRIVAX ASSET ACQUISITION

Source text: ID:nPn3vCc5sa

Further company coverage: [ELSn.MU]

 ((Reuters.Briefs@thomsonreuters.com;))